World · en
My son’s disease progressed while the FDA waited
Birthdays should mark milestones, offer hope for another year, and remind us to cherish the people we love. But on the first anniversary of the Food and Drug Administration’s decision to restrict access to Elevidys, a gene therapy for Duchenne muscular dystrophy, there will be no cake or candles in our home.…
